In vitro quantitation of Theileria parva sporozoites for use - TropMed ...
In vitro quantitation of Theileria parva sporozoites for use - TropMed ...
In vitro quantitation of Theileria parva sporozoites for use - TropMed ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
104 Chapter 8: SNA and refinement <strong>of</strong> titration protocol<br />
______________________________________________________________________________________________<br />
SNA based on the observation that immune serum interferes with sporozoite infectivity in <strong>vitro</strong> as<br />
described by Gray and Brown (1981).<br />
Typically, SNA's are carried out by incubating <strong>sporozoites</strong> with test sera (about 30 min) after which<br />
PBMC are introduced. <strong>In</strong> this system, antibodies have more time to interact with <strong>sporozoites</strong> be<strong>for</strong>e<br />
they contact and enter lymphocytes. This method is not very representative <strong>of</strong> in vivo events in<br />
which <strong>sporozoites</strong> are inoculated into a complex environment containing antibody and PBMC.<br />
Moreover, <strong>sporozoites</strong> invade target cells in a very short time (Shaw et al., 1991) and there<strong>for</strong>e,<br />
indications are that the period <strong>of</strong> exposure to antibodies is relatively shorter in vivo than the present<br />
SNA prescribes. There<strong>for</strong>e, it was desirable to attempt to approximate the natural process as closely<br />
as possible by introducing <strong>sporozoites</strong> into a culture <strong>of</strong> PBMC's containing test sera.<br />
The modifications were aimed at optimising the protocol <strong>for</strong> <strong>use</strong> in quantitating T. <strong>parva</strong>. The<br />
modifications not only address the maintenance <strong>of</strong> the viability <strong>of</strong> cells, but also provide <strong>for</strong> more<br />
efficient management <strong>of</strong> the culture system and reduced variability. Full descriptions <strong>of</strong> the existing<br />
procedures are given elsewhere (Musoke et al., 1984; Musoke et al., 1992; Marcotty et al., 2004)<br />
and a comparison <strong>of</strong> the original and refined protocols are presented in Appendices I and II. The<br />
stages that needed improvement were identified as: a) storage <strong>of</strong> PBMC, b) discontinuation <strong>of</strong><br />
PBMC stimulation with Con-A, c) replacement <strong>of</strong> microtubes, which are cumbersome and limit the<br />
number <strong>of</strong> repetitions that can be done per session, with 96-well plates <strong>for</strong> incubation, d) counting<br />
<strong>of</strong> positive wells rather than cells, e) incubation <strong>of</strong> antibody with PBMC and f) PCR reading <strong>of</strong><br />
cultures instead <strong>of</strong> microscopy.<br />
8.2. Materials and methods<br />
8.2.1. PBMC storage<br />
Collection and isolation <strong>of</strong> PBMC were as described in chapter 3. Cells were stained with<br />
carboxyfluoroscein succinimidyl ester (CFSE) at a pre-titrated concentration <strong>of</strong> 0.56µl per 1*10 7<br />
PBMC (Appendix V). The cell suspension was split into two 15 ml lots in 50 ml culture flasks, one<br />
flask was stored overnight in a refrigerator (4°C). The other was stored overnight at 37°C in an<br />
incubator (5% CO 2 in air) with the cap loosened.<br />
The following day, samples from the two flasks were analysed by flow cytometry (FACScan ® ,<br />
Becton Dickinson). Data were analysed in WinMDI ® version 2.8 based on 10,000 events acquired<br />
without any gating. Mean CFSE fluorescence in log units were obtained and dot plots <strong>of</strong> <strong>for</strong>ward